Tg(Dbh-COP4*L132C,-lacZ)B16-4Mik
Transgene Detail
|
Symbol: |
Tg(Dbh-COP4*L132C,-lacZ)B16-4Mik |
Name: |
transgene insertion B16-4, M I Kotlikoff |
MGI ID: |
MGI:6361518 |
Synonyms: |
B16-DbhBAC-CaCh2_IRES_lacZ |
Transgene: |
Tg(Dbh-COP4*L132C,-lacZ)B16-4Mik Location: unknown
|
Alliance: |
Tg(Dbh-COP4*L132C,-lacZ)B16-4Mik page
|
|
Strain of Origin: |
(C57BL/6J x SJL/J)F2
|
|
Transgene Type: |
|
Transgenic (Reporter) |
Mutation: |
|
Insertion
|
|
|
Mutation details: The ~188.5 kbp C57BL/6J mouse bacterial artificial chromosome (BAC) RP23-354N13 was obtained; containing the entire dopamine beta-hydroxylase locus (Dbh), as well as ~106 kbp centromeric flanking sequences (including the complete Adamtsl2 locus) and ~65 kbp telomeric flanking sequences (including the complete Sardh and Sardhos loci). Using homologous recombination/BAC recombineering, a 5640 bp CatCh-IRES-lacZ-pA construct was inserted into the ATG start site of the BAC Dbh gene. No other loci on the BAC were altered. The 11.6 kbp BAC vector (pBA Ce3.6) contained a chloramphenicol selection cassette. Founder line B16-4 was identified with high lacZ expression in the expected cells. The calcium translocating channelrhodopsin cDNA sequence used here encodes the first 309 amino acids of green alga Chlamydomonas reinhardtii channelrhodopsin-2 that has been modified with an L132C amino acid substitution (CTC-to-TGC) designed to cause enhanced Ca2+ permeability.
(J:314125)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:314125 Lee FK, et al., Genetically engineered mice for combinatorial cardiovascular optobiology. Elife. 2021 Oct 29;10:e67858 |
All: |
1 reference(s) |
|